These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36741237)

  • 1. Effect of blockchain technology initiatives on firms' market value.
    Ali HS; Jia F; Lou Z; Xie J
    Financ Innov; 2023; 9(1):48. PubMed ID: 36741237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEOs' psychological trait and firms' adoption of blockchain technology: The role of hometown identity.
    Wang L; Xiao W; Xie S; Wei R
    Front Psychol; 2022; 13():1005249. PubMed ID: 36467173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stock market returns and clinical trial results of investigational compounds: an event study analysis of large biopharmaceutical companies.
    Hwang TJ
    PLoS One; 2013; 8(8):e71966. PubMed ID: 23951273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Product Market Competition and Firm Performance: Business Survival Through Innovation and Entrepreneurial Orientation Amid COVID-19 Financial Crisis.
    Liu Q; Qu X; Wang D; Abbas J; Mubeen R
    Front Psychol; 2021; 12():790923. PubMed ID: 35411208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unveiling the role of supply chain parameters approved by blockchain technology towards firm performance through trust: The moderating role of government support.
    Shahzad MF; Xu S; Baheer R; Ahmad W
    Heliyon; 2023 Nov; 9(11):e21831. PubMed ID: 38028007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractal dimension analysis of stock prices of selected resulting companies after mergers and acquisitions.
    Verma SK; Kumar S
    Eur Phys J Spec Top; 2023 May; ():1-11. PubMed ID: 37359185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family Exit and Firms' Investment Efficiency Based on Dynamic Changes: Evidence from Chinese Family Firms.
    Wang T; Peng Q; Song H
    Comput Intell Neurosci; 2022; 2022():7572891. PubMed ID: 35958788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stock market reaction to COVID-19: Evidence from U.S. Firms' International exposure.
    Au Yong HH; Laing E
    Int Rev Financ Anal; 2021 Jul; 76():101656. PubMed ID: 36569818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How important is social trust during the COVID-19 crisis period? Evidence from the Fed announcements.
    Mazumder S
    J Behav Exp Finance; 2020 Dec; 28():100387. PubMed ID: 32868990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corporate climate risk and stock market reaction to performance briefings in China.
    Wu N; Xiao W; Liu W; Zhang Z
    Environ Sci Pollut Res Int; 2022 Jul; 29(35):53801-53820. PubMed ID: 35290587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can R&D investment reduce the impact of COVID-19 on firm performance?-Evidence from India.
    Biswas S
    J Public Aff; 2021 Oct; ():e2773. PubMed ID: 34899063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of the stock market reaction to the announcements of the UK Soft Drinks Industry Levy.
    Law C; Cornelsen L; Adams J; Penney T; Rutter H; White M; Smith R
    Econ Hum Biol; 2020 Aug; 38():100834. PubMed ID: 32081676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the Relationship Between Product Market Competition and Chinese Firms Performance: The Mediating Impact of Capital Structure and Moderating Influence of Firm Size.
    Mubeen R; Han D; Abbas J; Raza S; Bodian W
    Front Psychol; 2021; 12():709678. PubMed ID: 35662855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A look into the future of blockchain technology.
    Levis D; Fontana F; Ughetto E
    PLoS One; 2021; 16(11):e0258995. PubMed ID: 34788307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Firms' COVID-19 Pandemic Exposure and Corporate Cash Policy: Evidence from China.
    He Z; Suardi S; Wang K; Zhao Y
    Econ Model; 2022 Nov; 116():105999. PubMed ID: 36032988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why did they get in trouble? The influence of firm characteristics and institutional distance on Chinese firms' foreign market entry attempt.
    Zhang S
    Front Psychol; 2022; 13():972384. PubMed ID: 36148100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penalties for industrial accidents: The impact of the Deepwater Horizon accident on BP's reputation and stock market returns.
    McGuire W; Holtmaat EA; Prakash A
    PLoS One; 2022; 17(6):e0268743. PubMed ID: 35704560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockchain technology diffusion in tourism: Evidence from early enterprise adopters and innovators.
    Maythu Y; Kwok AOJ; Teh PL
    Heliyon; 2024 Jan; 10(2):e24675. PubMed ID: 38304774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Product line transformation, foreign sales, and firm value: Evidence from COVID-19 pandemic governance in urban China.
    Wang L; Yu J; Chan KC
    Res Int Bus Finance; 2021 Dec; 58():101487. PubMed ID: 36540340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Will the Volume-Based Procurement Policy Promote Pharmaceutical Firms' R&D Investment in China? An Event Study Approach.
    Hu Y; Chen S; Qiu F; Chen P; Chen S
    Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.